Recent Finacing
Recent Raise
Early is Good develops urine-based diagnostics; BCDx, a lab-developed test, uses a nanotechnology-based hybrid dual read-out to quantify protein, microRNA, mRNA and lncRNA biomarkers without extraction/amplification for bladder cancer detection.
